HomeCorporación GenzymeBúsquedaContáctenosSitios Web de Genzyme
Información CorporativaNuestras Áreas Del TratamientoNuestros Productos
Genzyme

Información Corporativa
Genzyme en Latinoamérica
Genzyme Argentina
Genzyme Chile
Genzyme Colombia
Genzyme México
Carreras Profesionales
Nuestra Investigación
Noticias de Genzyme
Presencia Global
Genzyme en Latinoamérica

Noticias de Genzyme

Genzyme
December 9, 2009Genzyme Laboratory Recognized for Quality
December 8, 2009Genzyme’s Mozobil Shows Promise in Chemosensitization
December 3, 2009Genzyme to Reopen Enrollment in Alglucosidase Alfa Temporary Access Program
November 17, 2009Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at AHA
November 16, 2009Genzyme Receives Complete Response Letter on Lumizyme Application
October 21, 2009Genzyme Reports Third-Quarter Financial Results
October 20, 2009First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
October 6, 2009Genzyme Receives FDA Complete Response Letter for Clolar
August 10, 2009Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
July 22, 2009Genzyme Delivers Solid Second-Quarter Financial Results
June 12, 2009Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease
June 2, 2009Genzyme Completes Transaction with Bayer HealthCare
March 2, 2009Genzyme Receives Complete Response Letter from FDA on Lumizyme Application
February 26, 2009European Authorities Approve Larger-Scale Production of Genzyme’s Myozyme
February 19, 2009Genzyme Receives Positive Opinion on Myozyme from CHMP
October 15, 2008Genzyme Begins Enrollment in Post-Marketing Study to Evaluate Use of Low Dose Fabrazyme Treatment for Fabry Disease
September 23, 2008Mozobil Receives Priority Review with FDA Action Expected by Year End; Synvisc-ONE FDA Action also Expected by Year End



Información de Contacto:
Genzyme de Argentina S.A.
Fondo de la Legua 161
(B1609JEB) Boulogne,
Provincia de Buenos Aires,
Argentina
T: + 54 11 4708-6900
F: + 54 11 4700-8111
www.genzyme.com.ar

Genzyme Chile Ltda.
Isidora Goyenechea 2800 Oficina 4102
Las Condes, Santiago de Chile
T: + 56 2 428 2800
www.genzyme.cl

Genzyme de Colômbia S. A.
Calle 93 B #17–25/49, Piso 5
Bogotá, Colombia
T: + 57 1 621 6600
F: + 57 1 621 6677
www.genzyme.com.co

Genzyme de Peru S.A.C
Calle Víctor Andrés Belaúnde
No147, Edif. Real 6, Piso 6, San Isidro.
Lima, Peru
T: + 51 1 2112576

Genzyme México S. de R.L. de C.V.
Paseo de la Reforma 505
Piso 49 Col. Cuauhtémoc
México Distrito Federal, C.P. 06500
México
T: + 52 55 5241 0600
F: + 52 55 5241 0659
www.genzyme.com.mx

Genzyme do Brasil Ltda.
São Paulo
Av. Francisco Matarazzo, 1400
10º andar - Conj. 101 - Edifício Milano
Água Branca
05001-903 - São Paulo – SP
SAC: 0800 77 123 73
T: +55 (11) 3874-9950
F: +55 (11) 3874-9952
www.genzyme.com.br

São Paulo
Rua Padre Chico, 224
Vila Pompéia
05008 - 010 - São Paulo – SP
T: +55 (11) 3872-5761

Rio de Janeiro
Praça Floriano, 19 - 26º andar – Centro
20031-050 - Rio de Janeiro – RJ
T: +55 (21) 2156-9950
F: +55 (21) 2156-9952

Términos y Condiciones de Uso | Política de Privacidad | © 2012 Genzyme Corporation, a Sanofi company. Todos los Derechos Reservados.